Literature DB >> 10620360

HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms.

R Cai1, B Carpick, R F Chun, K T Jeang, B R Williams.   

Abstract

Replication of the human immunodeficiency virus type 1 (HIV-1) is inhibited by interferons (IFNs), in part through activity of the IFN-inducible protein kinase PKR. To escape this antiviral effect, HIV-1 has developed strategies for blocking PKR function. We have previously shown that the HIV-1 Tat protein can associate with PKR in vitro and in vivo and inhibit PKR activity. Here we present evidence that Tat can inhibit PKR activity by both RNA-dependent and RNA-independent mechanisms. Tat inhibited PKR activation by the non-RNA activator heparin, and also suppressed PKR basal level autophosphorylation in the absence of RNA. However, when Tat and dsRNA were preincubated, the amount of Tat required to inhibit PKR activation by dsRNA depended on the dsRNA concentration. In addition to its function in vitro, Tat can also reverse translation inhibition mediated by PKR in COS cells. The Tat amino acid sequence required for interaction with PKR was mapped to residues 40-58, overlapping the hydrophobic core and basic region of HIV-1 Tat. Alignment of amino acid sequences of Tat and eIF-2alpha indicates similarity between the Tat-PKR binding region and the residues around the eIF-2alpha phosphorylation site, suggesting that Tat and eIF-2alpha may bind to the same site on PKR. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620360     DOI: 10.1006/abbi.1999.1583

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  32 in total

1.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

2.  Are viral-encoded microRNAs mediating latent HIV-1 infection?

Authors:  Marc S Weinberg; Kevin V Morris
Journal:  DNA Cell Biol       Date:  2006-04       Impact factor: 3.311

Review 3.  The roles of microRNAs in mammalian virus infection.

Authors:  Ralph Grassmann; Kuan-Teh Jeang
Journal:  Biochim Biophys Acta       Date:  2008-05-15

Review 4.  Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.

Authors:  Elena Herrera-Carrillo; Ying Poi Liu; Ben Berkhout
Journal:  Hum Gene Ther Methods       Date:  2017-08       Impact factor: 2.396

5.  Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response.

Authors:  Chi L Ong; Janine C Thorpe; Paul R Gorry; Sylvie Bannwarth; Anthony Jaworowski; Jane L Howard; Sean Chung; Shahan Campbell; Helen S Christensen; Guerline Clerzius; Andrew J Mouland; Anne Gatignol; Damian F J Purcell
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 6.  Plasmacytoid dendritic cells in HIV infection.

Authors:  Meagan O'Brien; Olivier Manches; Nina Bhardwaj
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Activation of GCN2 upon HIV-1 infection and inhibition of translation.

Authors:  Ophélie Cosnefroy; Anaïs Jaspart; Christina Calmels; Vincent Parissi; Hervé Fleury; Michel Ventura; Sandrine Reigadas; Marie-Line Andréola
Journal:  Cell Mol Life Sci       Date:  2013-02-17       Impact factor: 9.261

8.  Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies.

Authors:  Mariana Marin; Sheetal Golem; Susan L Kozak; David Kabat
Journal:  Virus Res       Date:  2015-11-25       Impact factor: 3.303

9.  Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

10.  ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.

Authors:  Guerline Clerzius; Jean-François Gélinas; Aïcha Daher; Marion Bonnet; Eliane F Meurs; Anne Gatignol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.